4.7 Article

Deep learning based pipelines for Alzheimer's disease diagnosis: A comparative study and a novel deep-ensemble method

Journal

COMPUTERS IN BIOLOGY AND MEDICINE
Volume 141, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.compbiomed.2021.105032

Keywords

Alzheimer's disease; Computer-aided diagnosis; Convolutional neural networks; Deep learning; MRI image Analysis; Image classification

Funding

  1. Algorithms and Models for Imaging Science [AMIS] [RASSR57257]

Ask authors/readers for more resources

This study aims to contribute to Alzheimer's disease research through computer-aided diagnosis by comparing different deep learning models. By conducting a comprehensive analysis on MRI and fMRI public datasets, the proposed approach achieved excellent accuracy in both binary and multiclass classification tasks.
Background: Alzheimer's disease is a chronic neurodegenerative disease that destroys brain cells, causing irreversible degeneration of cognitive functions and dementia. Its causes are not yet fully understood, and there is no curative treatment. However, neuroimaging tools currently offer help in clinical diagnosis, and, recently, deep learning methods have rapidly become a key methodology applied to these tools. The reason is that they require little or no image preprocessing and can automatically infer an optimal representation of the data from raw images without requiring prior feature selection, resulting in a more objective and less biased process. However, training a reliable model is challenging due to the significant differences in brain image types.Methods: We aim to contribute to the research and study of Alzheimer's disease through computer-aided diagnosis (CAD) by comparing different deep learning models. In this work, there are three main objectives: i) to present a fully automated deep-ensemble approach for dementia-level classification from brain images, ii) to compare different deep learning architectures to obtain the most suitable one for the task, and (iii) evaluate the robustness of the proposed strategy in a deep learning framework to detect Alzheimer's disease and recognise different levels of dementia. The proposed approach is specifically designed to be potential support for clinical care based on patients' brain images.Results: Our strategy was developed and tested on three MRI and one fMRI public datasets with heterogeneous characteristics. By performing a comprehensive analysis of binary classification (Alzheimer's disease status or not) and multiclass classification (recognising different levels of dementia), the proposed approach can exceed state of the art in both tasks, reaching an accuracy of 98.51% in the binary case, and 98.67% in the multiclass case averaged over the four different data sets.Conclusion: We strongly believe that integrating the proposed deep-ensemble approach will result in robust and reliable CAD systems, considering the numerous cross-dataset experiments performed. Being tested on MRIs and fMRIs, our strategy can be easily extended to other imaging techniques. In conclusion, we found that our deep ensemble strategy could be efficiently applied for this task with a considerable potential benefit for patient management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available